Close

ALXN Financial Facts

Total operating expenses: 497.78M
Cost of sales: 60.63M
See Full Income Statement

Accumulated other comprehensive loss: 694K
Goodwill: 5.04B
See Full Balance Sheet

Alexion Pharmaceuticals, Inc. (ALXN) Earnings

  |   Expand Research on ALXN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +18.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/30/21 Q121 $3.52$3.16 +$0.36$1.64B$1.58B N/A Details
2/4/21 Q420 $2.96$2.56 +$0.40$1.59B$1.52B N/A Details
10/29/20 Q320 $3.24$2.58 +$0.66$1.59B$1.42B = Details
7/30/20 Q220 $3.11$2.59 +$0.52$1.44B$1.28B = Details
5/6/20 Q120 $3.22$2.71 +$0.51$1.44B$1.36B = Details
1/30/20 Q419 $2.71$2.60 +$0.11$1.38B$1.31B = Details
10/23/19 Q319 $2.79$2.47 +$0.32$1.26B$1.24B Details
7/24/19 Q219 $2.64$2.34 +$0.30$1.2B$1.17B Details